VHI
Valhi, Inc.
VHI's fundamentals are mixed, but it looks expensive: trading at 336x earnings, about 39 times its usual 8.5x.
VHI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
VHI's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
VHI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.7x | $0.24 | -99% |
| Fair | 8.4x | $0.42 | -97% |
| Expensive | 20x | $1.01 | -94% |
| Current | 336x | $16.80 | — |
Historical ranges are pointers, not guarantees.
VHI's PE is in its expensive range at 336x.
VHI Forward outlook
There aren't enough analyst estimates for VHI to show an outlook.
VHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.05 | -92% |
| Q2 2026 | -$1.79 | -152% |
| Q1 2026 | -$2.54 | -162% |
| Q4 2025 | -$2.02 | -153% |
| Q3 2025 | $0.65 | -79% |
| Q2 2025 | $3.44 | +282% |
| Q1 2025 | $4.11 | +20450% |
| Q4 2024 | $3.79 | +$4.21 |
VHI's earnings per share have fallen from their peak: $0.05 over the past year, against $5.76 in mid-2022.
VHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $589M | +17% |
| Q2 2026 | $606.1M | +12% |
| Q1 2026 | $560.1M | +4% |
| Q4 2025 | $494.5M | +2.8% |
| Q3 2025 | $503.5M | -5.6% |
| Q2 2025 | $540.4M | -3.4% |
| Q1 2025 | $538.6M | +1.5% |
| Q4 2024 | $480.9M | +6.2% |
VHI's revenue has grown year over year for four quarters in a row: $589M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | +9.7 points |
| Q2 2026 | 11% | +4.6 points |
| Q1 2026 | 5.9% | -3.4 points |
| Q4 2025 | -6.3% | -18 points |
| Q3 2025 | 1.7% | -11 points |
| Q2 2025 | 6.6% | -3.2 points |
| Q1 2025 | 9.3% | +3.4 points |
| Q4 2024 | 12% | +8 points |
VHI's operating margin was 11% last quarter, up 9.7 points from the same quarter a year ago.
VHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $43.6M | +$55.9M |
| Q2 2026 | $41.9M | +360% |
| Q1 2026 | -$56.7M | +$112M |
| Q4 2025 | $89.8M | +170% |
| Q3 2025 | -$12.3M | -415% |
| Q2 2025 | $9.1M | -69% |
| Q1 2025 | -$168.7M | -$114.9M |
| Q4 2024 | $33.3M | -44% |
VHI's free cash flow has turned positive again: $119M over the past year, against −$139M the year before.
VHI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 2.6x | Moderate |
| Q1 2026 | 3.8x | Elevated |
| Q4 2025 | 2.9x | Moderate |
| Q3 2025 | 2.2x | Moderate |
| Q2 2025 | 1.6x | Healthy |
| Q1 2025 | 1.4x | Healthy |
| Q4 2024 | 0.8x | Very low |
VHI's net debt is about 1.6 years of its operating earnings (EBITDA), down from 2.2 years a year ago.
VHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.7 | Neutral |
| Stochastic | 40.8 | Neutral |
VHI's weekly RSI is 58 (neutral) and its Stochastic is 41 (neutral).
VHI PE vs Basic Materials Sector
| Metric | VHI | Sector median | Relative |
|---|---|---|---|
| PE | 336x | 19x | 1,705% above |
| PE % | 96 | 40 | 56 pts above |
VHI is trading at 336x earnings, a 1705% premium to the Basic Materials sector's median of 19x.
VHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $15.1 | 11% above |
| 20 week MA | $15.5 | 8.5% above |
| 50 week MA | $14.5 | 16% above |
| 100 week MA | $15.8 | 6.6% above |
| 200 week MA | $17.1 | 1.7% below |
VHI has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 1.7% below its 200-week average.
VHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.1 | $17.0 | -23% |
| 2021 | $17.0 | $27.4 | +62% |
| 2022 | $27.4 | $22.3 | -19% |
| 2023 | $22.3 | $15.2 | -32% |
| 2024 | $15.2 | $22.3 | +47% |
| 2025 | $22.3 | $12.1 | -46% |
| 2026 YTD | $12.1 | $16.8 | +39% |
VHI is up 39% so far in 2026, after finishing lower in four of the previous six years.